Anne Prener
CIK 1797917 · last filed 2025-06-20
Anne Prener is a corporate insider who has filed 12 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for GLTO, was dated Jun 20, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
12
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | — | $28.69 | — | $0 | 6 | 2025-06-20 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | — | $0.08 | — | $0 | 3 | 2022-05-13 |
| Kaleido Biosciences, Inc. (KLDO) Delisted | Director | — | $0.29 | — | $0 | 3 | 2021-07-01 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-20 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-13 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-01 | Kaleido Biosciences, Inc. (KLDO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-28 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-13 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-08 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-01 | Kaleido Biosciences, Inc. (KLDO) Delisted | Grant (A) | — | $0 | EDGAR |